Akero Therapeuticsw

Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis
Fierce Biotech
Tue, 09/13/22 - 10:40 am
Akero Therapeuticsw
NASH
liver fibrosis
clinical trials
efruxifermin